المؤلفون: Krawiec, Paulina, Mełges, Beata, Pac-Kożuchowska, Elżbieta, Mroczkowska-Juchkiewicz, Agnieszka, Czerska, Kamila

مصطلحات موضوعية: Familial partial lipodystrophy, LMNA gene, steatohepatittis

العلاقة: http://www.biomedcentral.com/1471-2431/16/38Test

الإتاحة: http://www.biomedcentral.com/1471-2431/16/38Test

المؤلفون: Oliveira, Joana, Freitas, Paula, Lau, Eva, Carvalho, Davide

مصطلحات موضوعية: Acquired partial lipodystrophy, Barraquer–Simons syndrome, Cephalothoracic lipodystrophy, Adipose tissue, Hypocomplementemia

العلاقة: http://www.biomedcentral.com/1756-0500/9/175Test

الإتاحة: http://www.biomedcentral.com/1756-0500/9/175Test

المصدر: Phase II Study of Growth Hormone Inhibition Using Pegvisomant In Severe Insulin Resistance

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT05470504Test

Other URLs: https://clinicalstudies.info.nih.gov/cgi/detail.cgi?A_000756-DK.htmlTest

المصدر: A 12-Month Randomized, Multicenter, Double-Blind, Placebo-Controlled Phase 3 Study to Evaluate the Safety and Efficacy of Daily Subcutaneous Metreleptin Treatment in Subjects With Partial Lipodystrophy

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT05164341Test

المصدر: A Randomized Double-Blind Placebo-Controlled Study of the LEPR Agonist Antibody REGN4461 for the Treatment of Metabolic Abnormalities in Patients With Familial Partial Lipodystrophy

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT05088460Test

المصدر: Study of Cortisol Metabolism in Familial Partial Lipodystrophy Type 2

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT04845165Test

المؤلفون: Ionis Pharmaceuticals, Inc.

المصدر: An Open-label Phase 2 Study of ISIS 703802 (AKCEA-ANGPTL3-LRx) Administered Subcutaneously to Subjects With Familial Partial Lipodystrophy

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT03514420Test

المساهمون: Elif Oral, Professor of Medicine

المصدر: An Investigator-Initiated Open-Label, Randomized Study of Gemcabene in Adults With Familial Partial Lipodystrophy Disease (FPLD)

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT03508687Test

المساهمون: Abhimanyu Garg, Chairman, Division Nutrition and Metabolic Diseases, Professor Internal Medicine

المصدر: Double-Blind, Placebo-Controlled Trial of Leptin Replacement Therapy in Patients With Lipodystrophy

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT00896298Test

المساهمون: Elif Oral, Professor, Internal Medicine

المصدر: Expanded-Access for the Use of Metreleptin in Patients With Partial Lipodystrophy Associated With Diabetes Mellitus or Hypertriglyceridemia

الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT02404896Test